Private equity-driven merger and acquisition activity in cardiology peaked in 2023, followed by a decline in 2024, according to a corporate finance report released in October 2024 by KPMG.
Continued demand for cardiovascular services alongside advancements in healthcare technology has made cardiology a target of private equity investment in the last five years.
Here’s a year-by-year breakdown of PE-driven cardiology transactions as of October 2024:
• 2024: 12
• 2023: 28
• 2022: 12
• 2021: 4
• 2020: 7
• 2019: 10
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
